Metformin, a drug used to lower insulin levels in diabetics, has been shown to halt tumor progression by cutting cancer cells’ energy supply.
A new Northwestern Medicine study found a gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer has fewer side effects than the same drug taken in oral form.
Scientists from Northwestern Medicine and the University of Chicago identified elevated levels of a regulatory protein called beta-catenin in the T-cells of patients with colon cancer.
A recently published Northwestern Medicine study uses math models based on the physical interactions within cells to make predictions of how gene transcription might be effected.
Radioembolization may offer an alternative to chemotherapy for breast cancer patients whose tumors have spread to the liver.
One of more than a dozen connected papers to be published in the American Journal of Public Health, a recent study has shown that Lesbian, Gay, Bisexual or Transgender youths make an increased number of choices that elevate their risk of cancer.
A Northwestern Medicine study finds more frequent testing combined with automated reminders yields dramatic improvements in colorectal cancer screening rates among low-income and minority communities.
David Kamp, MD, completed his residency and fellowship at Northwestern, where he now studies a range of lung disorders as well as cellular apoptosis, a process of programmed cell death.
A new study has found that large racial/ethnic disparities in colorectal cancer screening persist in America, including substantial differences between English-speaking and Spanish-speaking Hispanics. The research confirmed continued low screening rates among all residents of the U.S.
Recently published research in Human Molecular Genetics shows that removing too much of the enzyme HDAC3 has a toxic effect on the nervous system. The expression of this enzyme is inhibited by drugs being studied as potential treatment options for cancer and neurodegeneration